DOUGLAS, Isle of Man--(BUSINESS WIRE)--Juvenescence, a biopharmaceutical development company focused on therapeutics for aging, and the Buck Institute for Research on Aging announce a new collaboration with the formation of BHB Therapeutics, Ltd, a joint venture. The company will focus on novel approaches to inducing a state of ketosis, which may have protective effects against age-related disease.
Sodium betahydroxybutyrate: RK Solutions, VND Butyrate v. Vitajoy USA Inc.